PrognomiQ

San Mateo, United States

PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.

$11.9M raised

Jan 2026

Venture - Series Unknown

Top Investors

Catalio Capital ManagementWing Venture CapitalFidelityMaverick VenturesInvus

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has PrognomiQ raised?

PrognomiQ has raised $11.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2026.

Who are PrognomiQ's investors?

PrognomiQ's investors include Catalio Capital Management, Wing Venture Capital, Fidelity, Maverick Ventures, Invus.

Where is PrognomiQ headquartered?

PrognomiQ is headquartered in San Mateo, United States.

What does PrognomiQ do?

PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.

What stage is PrognomiQ at?

PrognomiQ is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 16, 2026.

MLA

"PrognomiQ — Funding & Investors." VCBacked, January 16, 2026, https://www.vcbacked.co/company/prognomiq. Accessed June 3, 2026.

APA

VCBacked. (2026). PrognomiQ — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/prognomiq

Wikipedia (cite web)

{{cite web |title=PrognomiQ — Funding & Investors |url=https://www.vcbacked.co/company/prognomiq |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 16, 2026.